Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
Background: The efficacy and safety of immunosuppressive monotherapy agents were evaluated for immunoglobulin A nephropathy (IgAN) using a network meta-analysis approach.Methods: Randomized controlled trials (RCTs) published prior to October 1, 2019, using immunosuppressive agents for treating IgAN,...
Saved in:
Main Authors: | Shisheng Han (Author), Tianwen Yao (Author), Yan Lu (Author), Min Chen (Author), Yanqiu Xu (Author), Yi Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Agents in IgA Nephropathy: An Update Network Meta-Analysis
by: Pingping Yang, et al.
Published: (2018) -
Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
by: Mian-Na Luo, et al.
Published: (2023) -
Clinicopathological Characteristics, Role of Immunosuppressive Therapy and Progression in IgA Nephropathy with Hyperuricemia
by: Yiping Ruan, et al.
Published: (2018) -
Sulodexide in IgA nephropathy
Published: (2013) -
Clinical significance of IgA nephropathy with hyperuricemia
by: Han Zhou, et al.
Published: (2024)